Severe ulcerative colitis complicated by an arterial thrombus in the brachiocephalic trunk [2]

Inflammatory Bowel Diseases

Volumn 13, Issue 7, 2007, Pages 937-938

  Haumer, Markus ^a   Teml, Alexander ^a,b,c   Dirisamer, Albert ^a   Vogelsang, Harald ^a   Koppensteiner, Renate ^a   Novacek, Gottfried ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN A; HEPARIN; ILOPROST; LIDOCAINE; METRONIDAZOLE; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; UROKINASE;

ADULT; ANAMNESIS; ARTERY THROMBOSIS; BLOOD TESTIS BARRIER; BRACHIOCEPHALIC TRUNK; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANTICOAGULANTS; BRACHIOCEPHALIC TRUNK; COLITIS, ULCERATIVE; FEMALE; FINGERS; HUMANS; ISCHEMIA; MIDDLE AGED; THROMBOSIS;

EID: 34547629744     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20116     Document Type: Letter

References (8)

1. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease-specific risk factor for thromboembolism? Gut. 2004;53:542-548.
2. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140-145.
3. Novacek G, Haumer M, Schima W, et al. Aortic mural thrombi in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:430-435.
4. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J. 1989;298:82-86.
5. Martin M, Heimig T, Fiebach PJ, et al. Lysis block treatment: a new form of local thrombolysis. Angiology. 1994;45:143-148.
6. Oldenburg B, Fijnheer R, van der Griend R, et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications'? Am J Gastroenterol. 2000;95:2825-2830.
7. Samama MM, Cohen AT, Damron JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. New Engl J Med. 1999;341:793-800.
8. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S-400S.